Stanford University
Showing 2,691-2,700 of 12,914 Results
-
Elizabeth DiRenzo, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Music
Current Research and Scholarly InterestsDr. Erickson DiRenzo's laboratory integrates research techniques from the basic and clinical sciences to improve the prevention and management of voice disorders.
-
Vasu Divi, MD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Vasu Divi is a distinguished expert in the field of head and neck cancer treatment, renowned for his dual roles as a cancer surgeon and reconstructive surgeon. With a specialized focus on high-risk and advanced skin cancers, oral cavity cancers, and osteoradionecrosis of the head and neck, Dr. Divi stands at the forefront of medical innovation. As a national authority in cutaneous squamous cell carcinoma of the head and neck, Dr. Divi spearheads Stanford's clinical trial program dedicated to this condition. His trial portfolio encompasses both neoadjuvant and adjuvant applications of immunotherapy, reflecting his commitment to advancing treatment methodologies. Actively engaged in research, Dr. Divi endeavors to define the optimal treatment approach for this disease, integrating immunotherapy to enhance patient outcomes.
-
Anjali Dixit, MD, MPH
Instructor, Anesthesiology, Perioperative and Pain Medicine
BioI am a pediatric anesthesiologist and health services researcher. My research focuses on outcomes in pediatric and adult surgical patients, management of pain and use of opioids in the perioperative period, and prevention and treatment of substance use disorders. My clinical care and research are both grounded in a desire to provide safe, equitable healthcare to all patients, particularly during high-risk or stressful events such as surgery.
-
Scott Dixon
Professor of Biology
Current Research and Scholarly InterestsMy lab is interested in the relationship between cell death and metabolism. Using techniques drawn from many disciplines my laboratory is investigating how perturbation of intracellular metabolic networks can result in novel forms of cell death, such as ferroptosis. We are interested in applying this knowledge to find new ways to treat diseases characterized by insufficient (e.g. cancer) or excessive (e.g. neurodegeneration) cell death.
